Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
8,922,318
-
Share change
-
-1,191,472
-
Total reported value
-
$4,193,343
-
Price per share
-
$0.47
-
Number of holders
-
15
-
Value change
-
-$562,753
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q4 2022
As of 31 Dec 2022,
AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,922,318 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, Omnia Family Wealth, LLC, NEA Management Company, LLC, LPL Financial LLC, Hikari Power Ltd, Bryn Mawr Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.